August 10, 2026 · JAMA · DOI: 10.1001/jama.2026.13898

Liquid Biopsies for Cancer: A Translational Science Review

Listen to this summary

The authors investigate the role of circulating tumor DNA (ctDNA) in cancer management, specifically its potential for monitoring disease progression, detecting minimal residual disease, and guiding treatment decisions based on genetic variations. They highlight the correlation between ctDNA levels and patient outcomes, noting that ctDNA can provide earlier indications of relapse compared to traditional imaging methods. However, the study also emphasizes the need for clarity regarding the optimal timing for ctDNA testing and the management of results in clinical practice.

Jessica Mezzanotte-Sharpe, Katrina Piemonte, Ben H Park

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play